Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10.9% normal saline (control)----1件: 299
2Active Control----1件: 13
3Amitriptyline, fluoxetine and tramadol alone (control group)3件: Amitriptyline,
Fluoxetine,
Tramadol		6件: D00326 ,
D00809 ,
D00823 ,
D01355 ,
D07448 ,
D08623 		3件: OPRM1,
SLC6A2,
SLC6A4 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 78
4Behavioral: Assessment of severity of ICD (impulse control disorders)----1件: 6
5Behavioral: Attention Control----1件: 6
6Behavioral: Control Group Typically Developing----1件: 113
7Behavioral: Healthy age-matched controls----1件: 6
8Behavioral: Low-Impact Exercise Control----1件: 6
9Behavioral: Protein and calorie controlled diet----1件: 251
10Boots High Strength Garlic Odour Controlled1件: Garlic1件: D12020 --1件: 299
11BPR277 ointment (controlled application)----1件: 160
12Carbidopa and Levodopa Controlled Release Tablets2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
13Coenzyme Q-10 in Normal Control subjects1件: Ubidecarenone1件: D01065 --1件: 86
14Control----4件: 6, 46, 168, 299
15Control group----5件: 2, 34, 46, 70, 235
16Control Group 0.9% Isotonic Saline----1件: 299
17Control intervention (no dexamethasone)1件: Dexamethasone9件: D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
18Control multivitamin----1件: 299
19Controlled-release levodopa / carbidopa2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
20Cornstarch control1件: Starch, corn (Synonym: Lotrimin Daily Sweat and Odor Control)1件: D05297 --1件: 90
21Diagnostic Test: Blood analysis for hypercalcemia's control----1件: 18
22Diagnostic Test: blood drawing in healthy controls----1件: 65
23Diazoxide choline controlled-release tablet2件: Choline,
Diazoxide		2件: D00294 ,
D07690 		2件: ABCC8,
KCNJ11 💬		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 193
24Epilim Chrono 200 Controlled Released tablets----1件: 256
25Epilim Chrono 300 Controlled Released tablets----1件: 256
26Epilim Chrono 500 Controlled Released tablets----1件: 256
27Group 1- Control Diet----1件: 97
28High dose vehicle control----1件: 46
29Histamine
(Synonym: POSITIVE SKIN TEST CONTROL - HISTAMINE)		1件: Histamine (Synonym: Histamine Positive Skin Test Control)1件: D08040 (Name: POSITIVE SKIN TEST CONTROL - HISTAMINE)4件: HRH1,
HRH2,
HRH3,
HRH4 💬		4件: Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13
30Infliximab Control1件: Infliximab1件: D02598 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
31Levodopa CR (controlled release)1件: Levodopa1件: D00059 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
32Low dose vehicle control----1件: 46
33Other: Control----9件: 6, 19, 67, 70, 75, 85, 97, 162, 193
34Other: Control Diet----1件: 96
35Other: Control group----1件: 2
36Other: Control group(Normal saline)----1件: 97
37Other: Control wound treatment----1件: 36
38Other: Controlled environment tests (series of tasks of everyday life)----1件: 6
39Other: Controls Primary Cervical Dystonia (Trihexyphenidyl)1件: Trihexyphenidyl2件: D00787 ,
D08638 		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6
40Other: DYT 1 Dystonia (Healthy Control)----1件: 6
41Other: healthy controls----1件: 63
42Other: Histamine
(Synonym: POSITIVE SKIN TEST CONTROL - HISTAMINE)		1件: Histamine (Synonym: Histamine Positive Skin Test Control)1件: D08040 (Name: POSITIVE SKIN TEST CONTROL - HISTAMINE)4件: HRH1,
HRH2,
HRH3,
HRH4 💬		4件: Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13
43Other: Historical control----1件: 2
44Other: Low Blood Pressure Control----1件: 67
45Other: No MSDMDs therapy (control)----1件: 13
46Other: Normal (control) diet----1件: 240
47Other: Observational Control----1件: 13
48Other: Parts A/B: Sham Control----1件: 19
49Other: Reaction Time and Postural Control----1件: 299
50Other: Standard Blood Pressure Control----1件: 67
51Oxycodone by patient-controlled analgesia (PCA)1件: Oxycodone (Synonym: Oxycodone HCl Controlled-Release)3件: D03783 ,
D05312 ,
D05462 		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 46
52Ropinirole controlled-release (REQUIP CR) for RLS1件: Ropinirole2件: D00784 ,
D08489 		3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
53Sinemet® controlled release (Carbidopa/levodopa)2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
54Vehice Control----1件: 96
55Vehicle Control----1件: 53